Purchase Order W81K0217P0448
Award Date 9/27/17
Potential Completion Date 9/30/19
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide the Oncotype DX portfolio of genomic cancer testing assays. The $149,624.97 award was issued as a Blanket Purchase Agreement (BPA) call by the Defense Health Agency, with firm fixed pricing. The contract supports the provision of Oncotype Breast Cancer Assay, Oncotype Genomic Prostate Score Assay, and Oncotype Colon Recurrence Score Assay testing services to Department of Defense and...
- This federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of the company's Oncotype DX portfolio of cancer diagnostic assays. The contract, valued at $200,327.28, was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA). It is a firm-fixed-price purchase order with a period of performance through September 30, 2025. The contract does not utilize a set-aside designation, as Genomic...
- This federal contract award is for Oncotype DX breast cancer testing services provided by Genomic Health, Inc. to the Defense Health Agency. The $13,815.84 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call, with a performance period ending on May 31, 2018. Genomic Health, a subsidiary of Exact Sciences Corporation, is a for-profit organization that specializes in providing advanced genetic testing services to federal healthcare systems. The company has several large Indefinite...
- This is a $6,385.84 firm fixed price contract awarded by the Department of Veterans Affairs to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype DX cancer testing services at a VA medical facility in St. Louis. The contract was issued under the VA's Medical Laboratory Testing and Analysis Services master schedule contract and runs through March 2021. Genomic Health, a leading provider of genomic-based cancer diagnostic tests to the federal government, has received...
- This federal contract award is for the provision of 2 Oncotype DX Pathology Tests by Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract was awarded by the Air Education and Training Command, a defense agency, and has a ceiling value of $6,907.92. It is a firm fixed-price delivery order contract under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does not have a set-aside designation. Genomic Health, Inc. is the...
- This is a firm fixed-price delivery order awarded by the Department of the Army Medical Command to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for its Oncotype DX portfolio of cancer diagnostic tests and services. The award, valued at $125,969.31, is issued under Genomic Health's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract with the General Services Administration. The services are being provided at Genomic Health's clinical laboratory...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
- This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...
- This is a firm fixed-price delivery order awarded by the Air Education and Training Command, a defense agency, to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of Oncotype DX Pathology Tests, which are advanced genomic cancer diagnostic services. This order is placed under the Medical Laboratory Testing and Analysis Services contract vehicle, a General Services Administration (GSA) schedule. Genomic Health provides these...
- This is a federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of the Oncotype portfolio of genomic tests to support patient care in anatomic pathology. The contract has a ceiling value of $145,066.32 and was awarded by the Defense Health Agency, a defense agency, on September 8, 2024. The contract type is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing structure, and an ultimate completion date of September 7,...